Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:43 pm Sale |
2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 3,223,851 2.900% |
-2,394,928 (-42.62%) |
Filing History |
| 2024-11-14 4:20 pm Sale |
2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-8,774,570 (Position Closed) |
Filing History |
| 2024-02-14 5:37 pm Purchase |
2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 5,618,779 5.800% |
386,500 (+7.39%) |
Filing History |
| 2024-02-14 10:13 am Purchase |
2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
BIOTECHNOLOGY VALUE FUND L P | 8,774,570 9.000% |
1,880,225 (+27.27%) |
Filing History |
| 2023-02-09 10:35 am Sale |
2022-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
JANUS HENDERSON GROUP PLC JHG |
2,114,519 2.200% |
-3,628,878 (-63.18%) |
Filing History |
| 2023-01-31 4:00 pm Purchase |
2022-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 19,963,157 21.100% |
1,839,265 (+10.15%) |
Filing History |
| 2022-11-23 12:28 pm Purchase |
2022-11-14 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 5,232,279 5.500% |
5,232,279 (New Position) |
Filing History |
| 2022-06-16 5:24 pm Purchase |
2022-06-06 | 13G | Centessa Pharmaceuticals plc CNTA |
BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.300% |
6,894,345 (New Position) |
Filing History |
| 2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
INDEX VENTURES LIFE VI (JERSEY) L.P. | 9,961,789 11.100% |
9,961,789 (New Position) |
Filing History |
| 2022-02-11 1:47 pm Purchase |
2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
JANUS HENDERSON GROUP PLC JHG |
5,743,397 6.400% |
5,743,397 (New Position) |
Filing History |
| 2022-02-08 08:27 am Purchase |
2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 18,123,892 20.160% |
18,123,892 (New Position) |
Filing History |
| 2021-06-11 4:59 pm Purchase |
2021-06-02 | 13D | Centessa Pharmaceuticals plc CNTA |
General Atlantic Cooperatief U.A. | 9,681,818 10.800% |
9,681,818 (New Position) |
Filing History |